Changes in serum osteocalcin levels in the follow-up of kidney transplantation

Annals of Clinical Biochemistry

Volumn 34, Issue 6, 1997, Pages 651-655

  Bonnin, M R ^a   Gonzalez, M T ^b   Grino J M ^b   Cruzado, J M ^b   Bover, J ^b   Martinez, J M ^a   Navarro, M A ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Markers of bone turnover; Parathyroid hormone; Steroid treatment

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CORTICOSTEROID; CREATININE; CYCLOSPORIN; LYMPHOBLAST ANTIBODY; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DEVELOPMENT; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0030853176     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329703400609     Document Type: Article

References (26)

1. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Mineral Res 1994; 9: 255-64
2. Worsfold M, Sharp CA, Davie MWJ. Serum osteocalcin and other indices of bone formation: an 8-decade population study in healthy men and women. Clin Chim Acta 1988; 178: 225-36
3. Malluche HH, Faugere MC, Fanti P, Price PA. Plasma levels of bone gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 1984; 26: 869-74
4. Gundberg CM, Weinstein RS. Muliple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest 1986; 77: 1762-7
5. Epstein S, Traberg H, Raja R, Poser J. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation. J Clin Endocrinol Metab 1985; 60: 1253-6
6. Gonzalez MT, Gonzalez C, Griñó JM, Castelao AM, Mariñoso ML, Serrano S, et al. Long-term evolution of renal osteodystrophy after kidney transplantation: comparative study between intact PTH levels and bone biopsy. Transplant Proc 1990; 22: 1407-11
7. Taylor AK, Lueken SA, Libanati C, Baylink DJ. Biochemical markers of bone turnover for the clinical assessment of bone metabolism. Clin N Am 1994; 20: 589-606
8. Boiskin I, Epstein S, Ismail F, Thomas SB, Raja R. Serum osteocalcin and bone mineral metabolism following successful renal transplantation. Clin Nephrol 1989; 31: 316-22
9. Bonnin MR, Gonzalez MT, Huguet J, Guillen E, Navarro MA. Serum osteocalcin levels in patients after kidney transplantation. Clin Nephrol 1990; 3: 255
10. Gundberg CM, Wilson PS, Gallop PM, Parfitt AM. Determination of osteocalcin in human serum: results with two kits compared with those by a well characterized assay. Clin Chem 1985; 34: 1720-3
11. Lukertand BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Int Med 1990; 112: 352-64
12. Kaspersen H, Charles P, Mosekilde L. The effect of single oral doses of predisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab 1988; 67: 1025-30
13. Griño JM, Alsina J, Sabater R, Castelao AM, Gil-Vernet S, Andres E, et al. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation. Transplantation 1990; 49: 1114-7
14. Griño JM, Castelao AM, Seron D, Gonzalez C, Galceran JM, Gil-Vernet S, et al. Antilymphocyte Globulin versus OKT3 induction therapy in cadaveric kidney transplantation: A prospective randomized study. Am J Kidney Dis 1992; 20: 603-10
15. Bonnin MR, Gonzalez MT, Arranz B, Rosel P, Navarro MA. Intact parathyrin in patients after kidney transplantation. Clin Chem 1988; 34: 2378
16. Coburn J. Renal osteodystrophy. Kidney Int 1980; 17: 677-93
17. Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Clin Nephrol 1991; 35: 78-85
18. Slatopolsky E, Delmez J. Bone disease in chronic renal failure and after renal transplantation. In: Disorders of Bone and Mineral Metabolism. Coe FL, Fabus J, eds. Raven Press, 1992
19. Alsina J, Gonzalez MT, Bonnin MR, Ricart Y, Castelao AM, Gonzalez C, et al. Long-term evolution of renal osteodystrophy after renal transplantation. Transplant Proc 1989; 21: 2151-8
20. Dempster DW. Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Min Res 1989; 4: 137-41
21. Prummer M, Wiersinga WM, Lips P, Sanders GTB, Saurwein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991; 72: 382-6
22. Gonzalez MT, Gonzalez C, Bover J, Bonnin MR, Mariñoso ML, Serrano S, et al. Does immunosuppressive therapy influence the recovery of bone disease in kidney transplant recipients? Transplant Proc 1992; 24: 99-102
23. Charhon SA, Delmas PD, Malaval L, Chavassieux PM, Arlot M, Chapuy MC, et al. Serum bone glaprotein in renal osteodystrophy: comparison with bone histomorphometry. J Clin Enclocrinol Metab 1986; 63: 892-7
24. Duda RJJ, O'Brien JF, Katzmann JA, Peterson JM, Mann KG, Riggs BL. Concurrent assays of circulating bone Gla-protein and bone alkaline phosphatase; effects of sex, age and metabolic bone disease. J Clin Endocrinol Metab 1988; 66: 951-7
25. Kaspersen H, Thomsen K, Ericsen EF, Charles P, Storm T, Mosekilde L. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Min 1988; 4: 105-13
26. Amado JA, Riancho JA, de Francisco ALM, Cotorruelo JG, Feijenes J, Arias M, et al. Hyperparathyroidism is responsible for the increased levels of osteocalcin in patients with normally functioning kidney grafts. Nephron 1989; 52: 209-15